Chitrang Trivedi

769 total citations
11 papers, 420 citations indexed

About

Chitrang Trivedi is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Chitrang Trivedi has authored 11 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in Chitrang Trivedi's work include Peroxisome Proliferator-Activated Receptors (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Adipose Tissue and Metabolism (3 papers). Chitrang Trivedi is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Adipose Tissue and Metabolism (3 papers). Chitrang Trivedi collaborates with scholars based in India, United States and Israel. Chitrang Trivedi's co-authors include Suresh Giri, Mukul R. Jain, Ramchandra Ranvir, Pankaj Patel, Akshyaya Rath, Hiren Patel, Nabanita Das, Walter Wahli, Sib Sankar Roy and Stephen C. Woods and has published in prestigious journals such as Diabetes, Endocrinology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Chitrang Trivedi

10 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chitrang Trivedi India 8 224 144 93 92 77 11 420
Romina Vargas Chile 13 149 0.7× 173 1.2× 103 1.1× 73 0.8× 34 0.4× 23 478
C. Vargas Spain 11 201 0.9× 168 1.2× 154 1.7× 118 1.3× 45 0.6× 17 529
Sarah Will United States 15 130 0.6× 239 1.7× 163 1.8× 200 2.2× 27 0.4× 28 626
Hyeong Geug Kim South Korea 12 116 0.5× 165 1.1× 46 0.5× 41 0.4× 44 0.6× 18 468
Peter S. Griffin United States 6 230 1.0× 185 1.3× 157 1.7× 243 2.6× 23 0.3× 6 572
Dingjiu Bao United States 5 134 0.6× 207 1.4× 154 1.7× 170 1.8× 13 0.2× 7 548
Rok Won Heo South Korea 12 112 0.5× 127 0.9× 122 1.3× 55 0.6× 7 0.1× 13 406
Aurèle Besse‐Patin Canada 8 209 0.9× 299 2.1× 306 3.3× 83 0.9× 22 0.3× 11 634
Weichao Zhong China 13 131 0.6× 119 0.8× 32 0.3× 34 0.4× 62 0.8× 19 429
Lingchen Gao China 14 107 0.5× 347 2.4× 76 0.8× 26 0.3× 20 0.3× 18 635

Countries citing papers authored by Chitrang Trivedi

Since Specialization
Citations

This map shows the geographic impact of Chitrang Trivedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chitrang Trivedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chitrang Trivedi more than expected).

Fields of papers citing papers by Chitrang Trivedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chitrang Trivedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chitrang Trivedi. The network helps show where Chitrang Trivedi may publish in the future.

Co-authorship network of co-authors of Chitrang Trivedi

This figure shows the co-authorship network connecting the top 25 collaborators of Chitrang Trivedi. A scholar is included among the top collaborators of Chitrang Trivedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chitrang Trivedi. Chitrang Trivedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Giri, Suresh, Akshyaya Rath, Chitrang Trivedi, et al.. (2025). Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia. Vaccines. 13(9). 889–889.
2.
Jain, Mukul R., Suresh Giri, Chitrang Trivedi, et al.. (2025). Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes. Journal of Pharmacology and Experimental Therapeutics. 392(4). 103534–103534. 1 indexed citations
3.
4.
Jain, Mukul R., Suresh Giri, Chitrang Trivedi, et al.. (2018). ZYDG2, a Potent, Selective, and Safe GPR40 Agonist for Treatment of Type 2 Diabetes. Diabetes. 67(Supplement_1). 3 indexed citations
5.
Jain, Mukul R., Suresh Giri, Chitrang Trivedi, et al.. (2017). Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models. Liver International. 38(6). 1084–1094. 172 indexed citations
6.
Jain, Mukul R., Suresh Giri, Chitrang Trivedi, et al.. (2015). Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid‐lowering and insulin‐sensitizing effects in preclinical models. Pharmacology Research & Perspectives. 3(3). 73 indexed citations
7.
Trivedi, Chitrang, Yi‐Chun Loraine Tung, Dhiraj G. Kabra, et al.. (2015). Tachykinin-1 in the Central Nervous System Regulates Adiposity in Rodents. Endocrinology. 156(5). 1714–1723. 12 indexed citations
8.
Yi, Chun‐Xia, Omar Al–Massadi, Elizabeth Donelan, et al.. (2012). Exercise protects against high-fat diet-induced hypothalamic inflammation. Physiology & Behavior. 106(4). 485–490. 99 indexed citations
9.
Shah, Shailesh R., Suresh Pola, Priyanka Priyadarshini, et al.. (2010). Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists. Bioorganic & Medicinal Chemistry. 19(2). 771–782. 13 indexed citations
10.
Trivedi, Chitrang, et al.. (2006). Effect of Atorvastatin Treatment on Isoproterenol-Induced Myocardial Infarction in Rats. Pharmacology. 77(1). 25–32. 14 indexed citations
11.
Majithiya, Jayesh B., Arvind Parmar, Chitrang Trivedi, & R Balaraman. (2005). Effect of pioglitazone on l-NAME induced hypertension in diabetic rats. Vascular Pharmacology. 43(4). 260–266. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romina Vargas Breakdown of academic impact, for papers by C. Vargas Breakdown of academic impact, for papers by Sarah Will Breakdown of academic impact, for papers by Hyeong Geug Kim Breakdown of academic impact, for papers by Peter S. Griffin Breakdown of academic impact, for papers by Dingjiu Bao Breakdown of academic impact, for papers by Rok Won Heo Breakdown of academic impact, for papers by Aurèle Besse‐Patin Breakdown of academic impact, for papers by Weichao Zhong Breakdown of academic impact, for papers by Lingchen Gao
Rankless by CCL
2026